Colon Hydrotherapy - Colon hydrotherapy, or colon irrigation, is a cleansing method that uses warm, filtered water to gently flush the large intestine and remove accumulated waste and blockages.

Colon hydrotherapy, or colon irrigation, is a cleansing method that uses warm, filtered water to gently flush the large intestine and remove accumulated waste and blockages. Colon cleansing is an ancient practice based on the idea that toxic compounds from retained fecal material are absorbed into the bloodstream, leading to systemic illness, a concept known as autointoxication or “self-poisoning.” For thousands of years, people have linked bowel irregularity, particularly constipation, with poor health. Ancient medical texts, such as the 16th-century BC Egyptian Ebers Papyrus, described illnesses as arising from internal decay caused by decomposing waste in the intestines. The Egyptians, considering internal cleansing essential for health, also included a detailed description of the use of enemas in the Egyptian Ebers Papyrus. Even Hippocrates (c. 400 BCE), the “father of medicine,” recommended air and liquid enemas for various ailments. This idea persisted for millennia, influencing European medical theory in the 18th and 19th centuries, during which many Western physicians viewed constipation as a “disease of civilization” and a major contributor to a wide range of ailments.

The rise of germ theory in the late 19th century strengthened this belief since Louis Pasteur claimed to have demonstrated that bacteria could cause infection, albeit there is much controversy concerning the veracity of Pasteur’s work. However, the germ theory came to be accepted and therefore the colon, came to be seen as a “sewage pit” full of microbes that could poison the body if the waste was not emptied regularly. Studies from the 1880s further reinforced this view by showing that intestinal bacteria produced toxic by-products leading to the theory of intestinal autointoxication, which proposed that toxins from stagnant fecal matter could enter the bloodstream and trigger wide range of symptoms including headaches, indigestion, insomnia, and nervous disorders, and illnesses including cardiovascular conditions and CFCs (chronically fermenting cells or cancer). 

The dawning of the 20th century saw an abrupt pivot away from matters concerning health and its preservation to the exclusive focus on “disease”, now seen as the enemy of health. Health preservation was abandoned in favor of disease eradication. Therefore, all natural explanations, procedures and treatments were considered quackery leaving the discovery of weapons, e.g., pharmaceuticals, surgery, radiation and the like as the only legitimate use time, effort and money. Although, common to all medical or healing disciplines previously, health-preserving practices such as dietary regulation, detoxification, bowel maintenance, rest, activity, and other non-patentable measures were now reclassified as unscientific and dismissed as quackery. Their exclusion was not the result of disproof, but of their incompatibility with the Rockefellerian version of medicine; industrialized, standardized, and monetized.

Within this new framework, medicine ceased to ask how health is sustained and focused exclusively on how disease is eliminated. However, although conventional medicine today considers colon cleansing, at minimum a waste of time, modern research and especially that involving the rapidly expanding appreciation of the gut microbiome and its direct relationship with health, there is now an expanded clarity regarding this ancient concept of autointoxication.  

Large studies show that constipation is associated with oxidative stress, inflammation, growth retardation in children, chronic kidney disease progression, and cardiovascular mortality. Improving constipation in both animal models and children reduces oxidative stress and related health impacts. 

The discovered mechanism is increased intestinal permeability, commonly referred to as “leaky gut.” Under normal conditions, the gut lining forms a selective barrier that absorbs nutrients while preventing harmful ingested substances such as bacterial toxins from entering circulation. When this barrier becomes compromised due to poor diet, microbial imbalance (dysbiosis), and inflammation, larger particles, such as toxins, bacterial metabolites, and food components can “leak” uncontrollably into the bloodstream. This escape of unwanted substances into blood, also called endotoxemia, triggers inflammation, not only in the digestive tract but throughout the body. Over time, this state of chronic inflammation damages organs and blood vessels, impairs metabolic function, promotes insulin resistance, and disrupts the immune system.

Chronic low-grade inflammation caused by endotoxemia, (which is often measured by the levels of bacterial components called lipopolysaccharides, or LPS, in blood) has been linked to a variety of health conditions, including:

  • Type 2 diabetes
  • Cardiovascular and kidney conditions
  • Non-alcoholic fatty liver disease
  • Obesity
  • Neurodegenerative conditions (Alzheimer’s, Parkinson’s, ALS, MS etc.)
  • Autoimmune issues
  • Digestive disorders
  • CFCs (cancer)

Modern lifestyle factors, including processed foods, physical inactivity, chronic stress, frequent antibiotic use, and exposure to environmental toxins, create ideal conditions for gut barrier dysfunction and rising rates of chronic inflammation–related conditions.

How Can Colon Hydrotherapy Help?

Colon hydrotherapy differs from enemas in that it is performed by a trained therapist using a specialized device to control water flow, rather than being self-administered. While enemas typically reach only the lower part of the colon, the sigmoid colon, colon hydrotherapy delivers water throughout the entire colon to flush out its contents. During the procedure, warm, gently pressurized water is introduced into the colon to relax the intestinal muscles and soften stool. Therapists may also use abdominal massage to help release the trapped material. The procedure uses a closed system in which water entering and waste leaving the colon travel through separate pipes, ensuring a clean and comfortable experience. Water temperature and pressure are carefully monitored throughout a series of controlled fills and releases to maintain safety and effectiveness.

Because colon hydrotherapy reaches farther than enemas and does not rely on chemical stimulation like laxatives, it can remove more material from the large intestine during a single session. Therefore, its effects on the intestinal environment are more profound.

Restoring Digestion and Gut Motility

The colon, the final segment of the digestive system, absorbs water and eliminates waste, playing a critical role in digestive function. When waste remains in the colon for extended periods, it hardens, making its elimination more difficult. Trapped material on the intestinal walls interferes with water absorption (causing diarrhea) and natural peristalsis or muscle contractions, further exacerbating waste accumulation. This creates an environment that encourages the overgrowth of harmful bacteria which damages the mucosal barrier and impairs motility, thereby establishing a cycle in which constipation and microbial imbalance (dysbiosis) reinforce each other.   

Cleansing the colon restores natural bowel movements and can relieve issues such as constipation, diarrhea, bloating, and sluggish digestion. Clinical studies indicate that colonic irrigation can be an effective treatment for improving digestive function in individuals with irritable bowel syndrome (IBS), helping to enhance motility and reduce abdominal discomfort, bloating, and overall digestive distress.

However, even individuals with regular bowel movements can unknowingly experience “hidden constipation,” a condition in which waste gradually accumulates in pockets of the colon over time. During colon hydrotherapy sessions, it is not uncommon that therapist observes undigested food particles that have remained in the colon for months or even years passing through the waste-removal tube. This shows that material can remain longer than expected, making colon cleansing a necessary step to fully benefit from healthier dietary changes by clearing remnants of previous eating habits.

Comparative studies between Western populations and rural African communities show that people in modern societies often experience twice the stool transit time. Conditions associated with slower transit, including IBS and colon CFCs, are largely absent in non-Westernized societies, showing how low-fiber diets, overeating, stress, sedentary lifestyles, and exposure to pollutants and food additives all disrupt normal digestive functions, causing waste to accumulate in the colon faster than it is eliminated.

Healthy Gut Microbiome

The gut microbiome, a complex ecosystem of over 400 microbial species (bacteria, fungi, and viruses etc.) including beneficial, neutral, and potentially harmful organisms, plays a central role in digestion, nutrient absorption, metabolism, immune function, and maintaining the integrity of the intestinal barrier. 

Beneficial bacteria strengthen the gut barrier by producing short-chain fatty acids (SCFAs) mainly through the fermentation of dietary fiber. SCFAs, especially butyrate, serves as a primary energy source for colonocytes, supporting their metabolism, maintaining barrier function, and reducing oxidative stress and inflammation. SCFA-producing bacteria have also been shown to influence immune activity, including antitumor immune responses.

When the delicate balance of the microbiome is disrupted, harmful microbes can overgrow and damage the mucosal barrier, allowing unwanted substances to enter the bloodstream. Recent research has shown that persistent dysbiosis, impaired mucus integrity and disrupted peristalsis, is largely established and maintained by microbial biofilms. Biofilms are dense, resistant structures of microbial communities that adhere to the intestinal lining and food particles, and protect microbes from environmental stress, immune detection, and treatments such as antibiotics. Biofilms often develop in areas of slower transit, such as the ileum and cecum, where they can harbor pathogenic bacteria while reducing beneficial species. Prolonged stool retention may further support biofilm formation by allowing food residues and mucus to remain longer in the colon. Biofilms are now recognized as contributors to conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and gastrointestinal CFCs. 

By flushing the entire colon, colon hydrotherapy can mechanically disrupt biofilms and remove retained waste that can serve as fertile ground for harmful microbes. This resets the environment to favor the re-establishment of a healthier microbiome. After the procedure, probiotics are administered to help repopulate the gut with beneficial species. 

Enhanced Detoxification

The colon works closely with the liver to eliminate harmful substances from the body. Metabolic byproducts, environmental toxins, medications, and excess hormones processed by the liver are excreted into bile and ultimately eliminated through stool. Efficient clearance of this material is essential for maintaining healthy liver function and overall physiological balance.

When stool remains in the colon for extended periods, these substances are continuously reabsorbed into the bloodstream and returned to the liver to be processed again. This recycling places extra strain on the liver and compromises detoxification processes, increasing the overall toxin burden.

Colon hydrotherapy supports detoxification by removing retained waste, thereby reducing the number of substances available for reabsorption and easing the liver’s workload.

Since the intestines eliminate excess hormones processed by the liver, cleansing the colon and promoting regular bowel movements also supports hormonal balance. For example, studies show that faster stool elimination is associated with lower circulating estrogen levels, whereas prolonged stool retention can increase estrogen reabsorption, which has been linked to a higher risk of estrogen-related conditions such as breast CFCs.

Enhancing Immune Function

The gut can be considered the body’s largest immunological organ because of its constant exposure to foreign substances. With its vast surface area directly contacting the external environment, the gut encounters a continuous stream of antigens from food, microbes, and other ingested substances. Consequently, the digestive tract is surrounded by the Gut-Associated Lymphoid Tissue (GALT), a major immune compartment containing diverse immune cells that monitor and respond to potential threats.

When the colon contains large amounts of retained waste and harmful microbes, the immune system is forced to remain in a heightened state of alert. Over time, this weakens overall immune efficiency. Chronic digestive problems, particularly constipation, have been associated with impaired immune function, including decreased activity of T and B lymphocytes and neutrophils, all of which are essential for defending against infections and CFCs. In fact, the severity of constipation often correlates with the degree of immune dysfunction. Certain immune cells, such as CD161⁺ T cells, mainly CD8⁺ cytotoxic T cells, are heavily concentrated in the intestines, where they help protect against dietary and microbial antigens. These same T cells are also essential for identifying and eliminating CFCs. When the gut is overloaded with pathogens and trapped food particles, a large portion of these T-lymphocyte reserves are occupied in the gut, reducing their availability for systemic immune defense.

The purpose of colon cleansing is to reduce this immunological burden, freeing immune cells from continuous gut surveillance and allowing them to strengthen systemic defenses. One human study found that colon hydrotherapy increased the number of lymphocytes in peripheral blood, likely reflecting their migration out of GALT and into general circulation, where they can support broader immune functions.

How to Maintain Colon Health After Treatment

After cleansing the colon with colon hydrotherapy (ideally practiced regularly), several lifestyle and dietary strategies help maintain long-term colon health. These habits support the intestinal barrier, promote a balanced microbiome, increase SCFA production, reduce systemic inflammation, and strengthen immune function.

Effective Lifestyle and Dietary Habits

  • Fiber-rich, whole-food diet
  • Fermented foods
  • Adequate sleep and regular exercise
  • Reduced alcohol intake
  • Fasting: Even short fasting periods support gut repair. Research shows that a 24-hour fast can activate intestinal stem cells and enhance their regenerative capacity.

Probiotics

Probiotics help reinforce the intestinal barrier and reduce harmful bacteria. Most studied strains include:

  • Bifidobacterium (e.g., B. longum, B. animalis, B. breve)
  • Lacticaseibacillus (L. casei, L. rhamnosus GG, L. acidophilus, L. helveticus)
  • Ligilactobacillus salivarius
  • Limosilactobacillus reuteri
  • Lactiplantibacillus plantarum
  • Streptococcus thermophilus
  • Akkermansia muciniphila

Prebiotics

Prebiotics are fermentable fibers that selectively nourish beneficial bacteria such as Bifidobacteria and Lactobacilli. Effective prebiotics include:

  • β-glucan
  • Galactooligosaccharides
  • Fructooligosaccharides
  • Inulin
  • Resistant starch
  • Arabinoxylan & AX oligosaccharides
  • Cistanche deserticola polysaccharides

Polyphenols

Polyphenols from fruits, vegetables, tea, and herbs modulate the microbiome and strengthen the gut barrier. Important classes include:

  • Flavonoids (e.g., catechins, anthocyanins, quercetin)
  • Phenolic acids
  • Proanthocyanidins
  • Tannins

Other Supportive Compounds

Several nutrients and botanicals also enhance barrier function and reduce inflammation:

  • Rhubarb extract
  • Guava leaf extract
  • Capsaicin (from red chili peppers)
  • Astaxanthin
  • Berberine
  • Astragalus membranaceus
  • Marine peptides and seaweed polysaccharides

In short, by removing retained waste and harmful microbes, colon hydrotherapy supports digestion, strengthens gut barrier, reduces toxin burden and creates conditions that favor a healthier gut microbiome. A cleaner, less congested colon also reduces the constant immune activation caused by stagnant waste and redirects immune resources back to systemic defense which is required for the effective elimination of CFCs.

 

References

 

    • Baumgartner M, Lang M, Holley H, Crepaz D, Hausmann B, Pjevac P, Moser D, Haller F, Hof F, Beer A, Orgler E, Frick A, Khare V, Evstatiev R, Strohmaier S, Primas C, Dolak W, Köcher T, Klavins K, Rath T, Neurath MF, Berry D, Makristathis A, Muttenthaler M, Gasche C. Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis. Gastroenterology. 2021 Oct;161(4):1245-1256.e20. doi: 10.1053/j.gastro.2021.06.024. Epub 2021 Jun 17. PMID: 34146566; PMCID: PMC8527885.
    • Burkitt DP, Walker AR, Painter NS. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet. 1972 Dec 30;2(7792):1408-12. doi: 10.1016/s0140-6736(72)92974-1. PMID: 4118696.
    • César Machado MC, da Silva FP. Intestinal Barrier Dysfunction in Human Pathology and Aging. Curr Pharm Des. 2016;22(30):4645-4650. doi: 10.2174/1381612822666160510125331. PMID: 27160754.
    • Dixit D, Roy A, Shukla A, Sharma P, Mandal M. The Effects of Short- and Long-Term Ingestion of Plastic Toxin Bisphenol A on Gastrointestinal Transit Time in Rats. Cureus. 2024 Feb 6;16(2):e53694. doi: 10.7759/cureus.53694. PMID: 38455775; PMCID: PMC10918301.
    • Fu R, Li Z, Zhou R, Li C, Shao S, Li J. The mechanism of intestinal flora dysregulation mediated by intestinal bacterial biofilm to induce constipation. Bioengineered. 2021 Dec;12(1):6484-6498. doi: 10.1080/21655979.2021.1973356. PMID: 34517785; PMCID: PMC8806846.
    • Fuke N, Nagata N, Suganuma H, Ota T. Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors. Nutrients. 2019 Sep 23;11(10):2277. doi: 10.3390/nu11102277. PMID: 31547555; PMCID: PMC6835897.
    • Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2. PMID: 29097493; PMCID: PMC5827966.
    • He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR, Fu YX, Chen Y, Guo X. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metab. 2021 May 4;33(5):988-1000.e7. doi: 10.1016/j.cmet.2021.03.002. Epub 2021 Mar 23. PMID: 33761313.
    • Hsu HH, Leung WH, Hu GC. Treatment of irritable bowel syndrome with a novel colonic irrigation system: a pilot study. Tech Coloproctol. 2016 Aug;20(8):551-7. doi: 10.1007/s10151-016-1491-x. Epub 2016 May 19. PMID: 27194235; PMCID: PMC4960275.
    • Iiai T, Watanabe H, Suda T, Okamoto H, Abo T, Hatakeyama K. CD161+ T (NT) cells exist predominantly in human intestinal epithelium as well as in liver. Clin Exp Immunol. 2002 Jul;129(1):92-8. doi: 10.1046/j.1365-2249.2002.01886.x. PMID: 12100027; PMCID: PMC1906419.
    • Jandl B, Dighe S, Gasche C, Makristathis A, Muttenthaler M. Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities. Clin Microbiol Rev. 2024 Sep 12;37(3):e0013323. doi: 10.1128/cmr.00133-23. Epub 2024 Jul 12. PMID: 38995034; PMCID: PMC11391705.
    • Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis. 2005 Nov;37(11):838-49. doi: 10.1016/j.dld.2005.06.008. Epub 2005 Oct 5. PMID: 16169298.
    • Lassenius MI, Pietiläinen KH, Kaartinen K, Pussinen PJ, Syrjänen J, Forsblom C, Pörsti I, Rissanen A, Kaprio J, Mustonen J, Groop PH, Lehto M; FinnDiane Study Group. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care. 2011 Aug;34(8):1809-15. doi: 10.2337/dc10-2197. Epub 2011 Jun 2. PMID: 21636801; PMCID: PMC3142060.
    • Lewis SJ, Heaton KW, Oakey RE, McGarrigle HH. Lower serum oestrogen concentrations associated with faster intestinal transit. Br J Cancer. 1997;76(3):395-400. doi: 10.1038/bjc.1997.397. PMID: 9252210; PMCID: PMC2224051.
    • Lomer MC, Hutchinson C, Volkert S, Greenfield SM, Catterall A, Thompson RP, Powell JJ. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn’s disease. Br J Nutr. 2004 Dec;92(6):947-55. doi: 10.1079/bjn20041276. PMID: 15613257.
    • Lo BC, Chen GY, Núñez G, Caruso R. Gut microbiota and systemic immunity in health and disease. Int Immunol. 2021 Mar 31;33(4):197-209. doi: 10.1093/intimm/dxaa079. PMID: 33367688; PMCID: PMC8011437.
    • Macfarlane S, Macfarlane GT. Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut. Appl Environ Microbiol. 2006 Sep;72(9):6204-11. doi: 10.1128/AEM.00754-06. PMID: 16957247; PMCID: PMC1563644.
    • Mihaylova MM, Cheng CW, Cao AQ, Tripathi S, Mana MD, Bauer-Rowe KE, Abu-Remaileh M, Clavain L, Erdemir A, Lewis CA, Freinkman E, Dickey AS, La Spada AR, Huang Y, Bell GW, Deshpande V, Carmeliet P, Katajisto P, Sabatini DM, Yilmaz ÖH. Fasting Activates Fatty Acid Oxidation to Enhance Intestinal Stem Cell Function during Homeostasis and Aging. Cell Stem Cell. 2018 May 3;22(5):769-778.e4. doi: 10.1016/j.stem.2018.04.001. PMID: 29727683; PMCID: PMC5940005.
    • Mutlu EA, Comba IY, Cho T, Engen PA, Yazıcı C, Soberanes S, Hamanaka RB, Niğdelioğlu R, Meliton AY, Ghio AJ, Budinger GRS, Mutlu GM. Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome. Environ Pollut. 2018 Sep;240:817-830. doi: 10.1016/j.envpol.2018.04.130. Epub 2018 May 18. PMID: 29783199; PMCID: PMC6400491.
    • Nomura M, Nagatomo R, Doi K, Shimizu J, Baba K, Saito T, Matsumoto S, Inoue K, Muto M. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors. JAMA Netw Open. 2020 Apr 1;3(4):e202895. doi: 10.1001/jamanetworkopen.2020.2895. PMID: 32297948; PMCID: PMC7163404.
    • Raahave D, Loud FB. Additional faecal reservoirs or hidden constipation: a link between functional and organic bowel disease. Dan Med Bull. 2004 Nov;51(4):422-5. PMID: 16009067.
    • Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2. PMID: 29097494.
    • Snelson M, Coughlan MT. Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology. Nutrients. 2019 Jan 22;11(2):215. doi: 10.3390/nu11020215. PMID: 30678161; PMCID: PMC6413015.
    • Takii Y, Hashimoto S, Iiai T, Watanabe H, Hatakeyama K, Abo T. Increase in the proportion of granulated CD56+ T cells in patients with malignancy. Clin Exp Immunol. 1994 Sep;97(3):522-7. doi: 10.1111/j.1365-2249.1994.tb06120.x. PMID: 7521809; PMCID: PMC1534863.
    • Tian P, Yang W, Guo X, Wang T, Tan S, Sun R, Xiao R, Wang Y, Jiao D, Xu Y, Wei Y, Wu Z, Li C, Gao L, Ma C, Liang X. Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis. Nat Commun. 2023 Mar 27;14(1):1710. doi: 10.1038/s41467-023-37419-7. PMID: 36973277; PMCID: PMC10043027.
    • Tomkovich S, Dejea CM, Winglee K, Drewes JL, Chung L, Housseau F, Pope JL, Gauthier J, Sun X, Mühlbauer M, Liu X, Fathi P, Anders RA, Besharati S, Perez-Chanona E, Yang Y, Ding H, Wu X, Wu S, White JR, Gharaibeh RZ, Fodor AA, Wang H, Pardoll DM, Jobin C, Sears CL. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic. J Clin Invest. 2019 Mar 11;129(4):1699-1712. doi: 10.1172/JCI124196. PMID: 30855275; PMCID: PMC6436866.
    • Uchiyama-Tanaka Y. Colon irrigation causes lymphocyte movement from gut-associated lymphatic tissues to peripheral blood. Biomed Res. 2009 Oct;30(5):311-4. doi: 10.2220/biomedres.30.311. PMID: 19887728.
    • Vermorken AJ, Andrès E, Cui Y. Bowel movement frequency, oxidative stress and disease prevention. Mol Clin Oncol. 2016 Oct;5(4):339-342. doi: 10.3892/mco.2016.987. Epub 2016 Aug 10. PMID: 27703675; PMCID: PMC5038884.
    • Whorton J. Civilisation and the colon: constipation as the “disease of diseases”. BMJ. 2000 Dec 23-30;321(7276):1586-9. doi: 10.1136/bmj.321.7276.1586. PMID: 11124189; PMCID: PMC1119264.
    • Yong CQY, Valiyaveettil S, Tang BL. Toxicity of Microplastics and Nanoplastics in Mammalian Systems. Int J Environ Res Public Health. 2020 Feb 26;17(5):1509. doi: 10.3390/ijerph17051509. PMID: 32111046; PMCID: PMC7084551.

Dr. Lodi

Thomas Lodi has been practicing medicine for 35 years. Prior to attending medical school, Dr. Lodi practiced as a clinical psychologist during which time he was director of psychological services for a 240 bed in patient facility in Hawaii. After graduating from the University of Hawaii School of Medicine in 1985, Dr. Lodi served as a visiting Clinical Fellow at Columbia University College of Physicians and Surgeons in New York City, where he also underwent training in Internal Medicine. From 1991 to 1996, Dr. Lodi was appointed as Clinical Instructor of Medicine at the University of Hawaii School of Medicine.

Linda Fredrikson, MSc

Linda Fredrikson, MSc, is a biologist specializing in physiology. She holds both a bachelor’s and a master’s degree from the University of Helsinki, Finland, with additional training in nutrition science and phytotherapy (plant-based medicine).